针对性筛查方案对胎盘植入谱系或前置血管风险妊娠围产结局的影响
该回顾性研究比较了针对性筛查方案实施前后胎盘植入谱系和前置血管孕妇的围产结局,共纳入97例胎盘植入谱系和51例前置血管病例。方案实施后两种疾病的产前检出率均提高,围产结局也显著改善。作者认为标准化产前针对性筛查方案与孕产妇和新生儿结局改善相关。
要点
- 胎盘植入谱系产前检出率从43.1%(28/65)升至96.9%(31/32),P<.001。
- 前置血管产前检出率从50%(9/18)升至87.9%(29/33),P<.01。
- 方案实施后前置血管组5分钟Apgar评分≤5和脐带血pH<7的例数均减少。
核心结论
- 对具有胎盘植入谱系和前置血管危险因素的孕妇实施标准化产前针对性筛查方案与孕产妇和新生儿结局改善相关。
- 剖宫产率和辅助生殖技术使用率的持续增加凸显了在国家和国际层面制定培训项目和引入针对性筛查方案的必要性。
研究设计与样本
- 回顾性研究,每种疾病各纳入方案实施前后两个非同期队列:胎盘植入谱系为2004-1012年 vs 2013-2016年,前置血管为1988-2007年 vs 2008-2016年。
- 共纳入97例胎盘植入谱系和51例前置血管病例,均经分娩证实。
- 回顾研究期间诊断为胎盘植入谱系和前置血管的孕妇的临床报告并比较结局。
主要发现
- 胎盘植入谱系产前检出率方案实施前28/65例(43.1%)vs 实施后31/32例(96.9%),P<.001。
- 前置血管产前检出率方案实施前9/18例(50%)vs 实施后29/33例(87.9%),P<.01。
- 胎盘植入谱系队列估计失血量方案实施前1520±845 mL vs 实施后1168±707 mL,P<.01。
- 胎盘植入谱系队列术后住院时间方案实施前10.9±14.1天 vs 实施后5.7±2.2天,P<.05。
- 前置血管队列5分钟Apgar评分≤5的例数方案实施前5/18例(27.8%)vs 实施后1/33例(3%),P<.05;脐带血pH<7的例数方案实施前4/18例(22.2%)vs 实施后1/33例(3%),P<.05。
临床怎么用
- 作者认为,对具有胎盘植入谱系和前置血管危险因素的孕妇实施标准化产前针对性筛查方案与孕产妇和新生儿结局改善相关。
- 作者提出,剖宫产率和辅助生殖技术使用率的持续增加凸显了在国家和国际层面制定培训项目和引入针对性筛查方案的必要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Placenta accreta spectrum and vasa previa (VP) are congenital disorders of placentation associated with high morbidity and mortality for both mothers and newborns when undiagnosed before delivery. Prenatal diagnosis of these conditions is essential to allow multidisciplinary management and thus improve perinatal outcomes. OBJECTIVE: The objective of the study was to compare perinatal outcome in women with placenta accreta spectrum or vasa previa before and after implementation of targeted scanning protocols. STUDY DESIGN: This retrospective study included 2 nonconcurrent cohorts for each condition before and after implementation of the corresponding protocols (2004-1012 vs 2013-2016 for placenta accreta spectrum and 1988-2007 vs 2008-2016 for vasa previa). Clinical reports of women diagnosed with placenta accreta spectrum and vasa previa during the study periods were reviewed and outcomes were compared. RESULTS: In total, there were 97 cases of placenta accreta spectrum and 51 cases with vasa previa, all confirmed at delivery. In both cohorts, the prenatal detection rate increased after implementation of the scanning protocols (28 of 65 cases [43.1%] vs 31 of 32 cases [96.9%], P < .001, for placenta accreta spectrum and 9 of 18 cases [50%] vs 29 of 33 cases [87.9%], 87.9%, P < .01 for vasa previa). The perinatal outcome improved also significantly in both cohorts after implementation of the protocols. In the placenta accreta spectrum cohort, the estimated blood loss and the postoperative hospitalization stay decreased between periods (1520 ± 845 vs 1168 ± 707 mL, P < .01, and 10.9 ± 14.1 vs 5.7 ± 2.2 days, P < .05, respectively). In the vasa previa cohort, the number of 5 minute Apgar score ≤5 and umbilical cord pH <7 decreased between periods (5 of 18 cases [27.8%] vs 1 of 33 cases [3%]; P < .05, and 4 of 18 cases [22.2%] vs 1 of 33 cases [3%], P < .05, respectively). CONCLUSION: The implementation of standardized prenatal targeted scanning protocols for pregnant women with risk factors for placenta accreta spectrum and vasa previa was associated with improved maternal and neonatal outcomes. The continuous increases in the rates of caesarean deliveries and use of assisted reproductive technology highlights the need to develop training programs and introduce targeted scanning protocols at the national and international levels.
引用
- Melcer Y, Jauniaux E, Maymon S, et al. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. Am J Obstet Gynecol. 2018. PMID: 29353034. doi:10.1016/j.ajog.2018.01.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。